Skip to content
10-K

Annual Report

BIONOVATE TECHNOLOGIES CORP.

0001640334-20-002607

← back to feed
Filed
Oct 19, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Sep 8, 2020 59.42M sh
Operating Cash Flow FY 2020 · Jun 30, 2019 $0
Long Term Debt FY 2020 · Jun 30, 2019 $0
Current Liabilities FY 2020 · Jun 30, 2019 $332.29K
Total Liabilities FY 2020 · Jun 30, 2019 $332.29K
Current Assets FY 2020 · Jun 30, 2019 $0
Total Assets FY 2020 · Jun 30, 2019 $0
Sga Expense FY 2020 · Jun 30, 2019 $16.98K
Net Income FY 2020 · Jun 30, 2019 −$208.9K
Operating Income FY 2020 · Jun 30, 2019 −$56.54K
Revenue FY 2020 · Jun 30, 2019 $0
Cash And Equivalents FY 2020 · Jun 30, 2018 $0
Stockholders Equity FY 2020 · Jun 30, 2018 −$309.68K